Taken together, across both bouton subtypes, the combined reduction of gains and losses was represented as an overall decrease in the dynamic fraction of axonal boutons in the APP-GFP amyloidosis group, whereas the overall number of boutons (density) remained unchanged. This evidence concerns the gene APP and amyloidosis.